The next IIID presentation will be on Wednesday 18 March at 11am by Mr Dunhui (Oliver) Li, Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University.  His talk is titled “Antisense oligonucleotide-mediated exon skipping strategies as the treatment for rare diseases”.

The next IIID presentation will be on Wednesday 11 March at 11am by Craig McIntosh,
PhD Candidate, Molecular Therapy Laboratory,  Centre for Molecular
Medicine and Innovative Therapeutics, Murdoch University.  Craig’s talk is
titled “Antisense Oligonucleotide-Mediated Therapeutic Strategies for
Neurodegenerative Repeat Expansion Diseases”.  Please see attached flyer
for further information.

The next IIID presentation will be on Wednesday 23 October at 11am by Professor Bruce Gardiner, Professor, Chemistry and Physics, College of Science, Health, Engineering and Education, Murdoch University. Professor Gardiner’s talk is titled “Integrative physiology: systems biology on another scale".

The next IIID presentation will be on Wednesday 9 October at 11am by Dr Michaela Lucas, Clinical Immunologist and Immunopathologist, QE2 Medical Centre and Medical School, University of Western Australia. Dr Lucas’s talk is titled “Transplantation tolerance and rejection: New insights".

The next IIID presentation will be on Wednesday 25 September at 11am by Associate Professor Pilar Blancafort, Laboratory Head, Cancer Epigenetics, Harry Perkins Institute of Medical Research. Associate Professor Blancafort’s talk is titled “Epigenetic editing of cancer cells: discovery of new cancer drivers and synthetic tools for programmable control of the cancer phenotype”.

The next IIID presentation will be on Wednesday 18 September at 11.00 am by Assistant Professor Juliana Hamzah, Laboratory Head, Targeted Drug Delivery, Imaging and Therapy, Harry Perkins Institute of Medical Research and NHMRC/National Heart Foundation R.D. Wright Biomedical Fellow. Assistant Professor Hamzah’s talk is titled “New approach to treat fibrotic diseases”.

The next IIID presentation is on Wednesday 11 September at 10.30. This will be a joint presentation by Madhuri Chakravarthy and John Chen, Murdoch University and Perron Institute for Neurological & Translational Science. Madhuri’s talk is titled “Development of nucleic acid technologies towards tackling Neurological Diseases” and John’s subject is “Development of antisense oligonucleotides towards tackling Type II Diabetes, Solid Cancers and Duchene Muscular Dystrophy”. Please note the start time of the first presentation is 10.30.

The next IIID presentation is by Malika Boukhoubza and Ben Horgan, Consumer Advocates, Murdoch University, Consumer and Community Health Research Network. Their joint presentation is titled “An Introduction to Consumer and Community Involvement in Research”.

The next IIID presentation is by Professor Anthony Akkari, Head, Motor Neurone Disease Genetics and Therapeutics Research, Perron Institute for Neurological and Translational Science.  Professor Akkari’s talk is titled “Structural variation: the slippery slope to disease risk”.

The next IIID presentation will be on Wednesday 31 July at 11am by Professor Nigel Laing, Group Leader Neurogenetic Diseases Group, Centre for Medical Research, University of Western Australia, Harry Perkins Institute of Medical Research. Professor Laing’s talk is titled “Genetic disorders: what is the best that we can do?”.

The next IIID presentation will be on Wednesday 24 July at 11.00 am by Emeritus Professor Miranda Grounds, University of Western Australia. E/Professor Grounds’ talk is titled “Impact of ageing on neuromuscular diseases with focus on dysferlinopathies”.

The next IIID presentation on Wednesday 3 July at 11am will be by Professor Prue Hart, Head, Inflammation, Telethon Kids Institute. Professor Hart’s talk is titled “Can UV irradiation of skin regulate autoimmune disease?”.

The next IIID presentation will be on Wednesday 12 June at 11am by Associate Professor Patricia Price, School of Pharmacy and Biomedical Sciences, Curtin University.   A/Professor Price’s talk is titled “Understanding how CMV infection affects us all”. 

The next IIID presentation on Wednesday 5 June at 11am will be by Dr Dianne De Santis, Senior Medical Scientist, PathWest Laboratory Medicine, Fiona Stanley Hospital.  Dr De Santis’s talk is titled “The Next Generation in Transplantation”. 

The next IIID presentation will be on Wednesday 22 May at 11am by Professor Sulev Kõks, Perron Institute for Neurological and Translational Science.  Professor Kõks’s talk is titled “Genomics and pathogenic mechanisms of neurodegenerative diseases”. 

The next IIID presentation will be on Wednesday 15 May at 11am by Dr Peter Arthur, The University of Western Australia.  Dr Arthur’s presentation is titled “Identifying oxidative stress biomarker(s) in blood to track inflammation in Duchenne Muscular Dystrophy”.

The next IIID presentation is on Wednesday 17 April at 11am by Dr Harry Parekh, The University of Queensland.  Dr Parekh’s talk is titled ““Translating delivery platforms for pain management, brain cancer, medicinal cannabis and more – the story so far…”.  

The next IIID presentation on Wednesday 20 March at 11am is by Professor John Forrester, Lions Eye Institute, The University of Aberdeen.  Professor Forrester’s talk is titled “Autoimmunity, Autoinflammation and Infection:  The Question of Uveitis”.

The next IIID presentation will be on Wednesday 13 March at 11am by Dr Baca Chan, Institute for Respiratory Health, the University of Western Australia.  Dr Chan’s talk is titled “Modulation of innate immune signalling by murine cytomegalovirus”.  

The next IIID presentation is on Wednesday 6 March at 11am by Dr Silvana Gaudieri, Institute for Immunology & Infectious Diseases, Murdoch University and the University of Western Australia.  Dr Gaudieri’s talk is titled “Understanding host-pathogen co-evolution: from sanger sequencing to single cell genomics”.  

The next IIID presentation will be held on Wednesday 24 October at 11am by Dr Jori Symons, The Peter Doherty Institute for Infection and Immunity, University of Melbourne. Dr Symon’s talk is titled “Position matters: Determining the HIV integration landscape in individuals on ART”.

The next IIID presentation on Wednesday 19 September at 11am will be by Professor Wally Langdon, University of Western Australia.  Professor Langdon’s talk is titled “Improving cancer treatment by preventing chemotherapy-induced myelosuppression”. 

The next IIID presentation will be on Wednesday 12 September at 11am by Dr Joost Lesterhuis, John Stocker Research Fellow at the School of Medicine and Pharmacology Research Staff, University of Western Australia.  Dr Lesterhuis’s talk is titled “Unravelling the networks underlying successful immunotherapy responses in cancer”. 

The next IIID presentation will be on Wednesday 15 August at 11am by Dr Bree Foley, Telethon Kids Institute.  Dr Foley's talk is titled "Enhancing NK Cell Immunotherapy.

The next IIID presentation will be on Wednesday 8 August at 11am by Professor Mike Bunce, Trace and Environmental DNA (TrEnD) Laboratory, School of Molecular and Life Sciences, Curtin University. Professor Bunce's talk is titled “Why environmental DNA (eDNA) from sediments, seawater and fossils is transforming what we know about environments and how to manage them into the future”

The next IIID presentation on Wednesday 1st August at 11am will be by Dr Livia Carvalho, Lions Eye Institute, University of Western Australia.  Dr Carvalho’s talk is titled “Gene therapy for retinal degeneration: current challenges and advances”. 

The next IIID presentation will be on Wednesday 25 July at 11am by Dr Carla Mellough, The Lions Eye Institute, COV, University of Western Australia.  Dr Mellough's talk is titled "Making useful retinal tissue in vitro".  

The next IIID presentation on Wednesday 11 July at 11am will be by Professor Valérie Verhasselt, Larsson Rosenquist Foundation, Chair in Human Lactology, School of Molecular Sciences, University of Western Australia.  Professor Verhasselt’s talk is titled “Breastmilk drives early immune education: The good and the bad for allergy development”. 

The next IIID presentation will be on Wednesday 4 July at 11am by Mr Bao Tri Le, PhD Student, Centre for Comparative Genomics, Murdoch University.  Mr Le’s talk is titled “Development of novel chemically-modified splice-modulating antisense oligonucleotides for tackling Duchenne muscular dystrophy and solid cancers".

The next IIID presentation will be on Wednesday 27 June at 11am by Associate Professor Christopher Peacock, Deputy Director, Graduate Programs in Infectious Diseases, School of Biomedical Sciences,
Faculty of Health and Medical Sciences, The University of Western Australia.  Associate Professor Peacock’s talk is titled “The biOMe study: the OMICS of otitis media”.